liu.seSearch for publications in DiVA
Endre søk
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Effect of interleukin-6 and insulin resistance on early virological response of Egyptian chronic hepatitis C patients to combined pegylated interferon plus ribavirin therapy
Department of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Suez Canal University, Ismailia, Egypt.ORCID-id: 0000-0002-0463-1518
Department of Internal Medicine, Faculty of Medicine, Suez Canal University, Ismailia, Egypt.
Department of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Suez Canal University, Ismailia, Egypt.
Department of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Suez Canal University, Ismailia, Egypt.ORCID-id: 0000-0001-5394-9082
Vise andre og tillknytning
2013 (engelsk)Inngår i: Egyptian Liver Journal, ISSN 2090-6218, Vol. 3, nr 2, s. 21-27Artikkel i tidsskrift (Fagfellevurdert) Published
Abstract [en]

Background and aim: Response to hepatitis C virus (HCV)-specific therapy is variable but might be influenced by host factors. We studied whether interleukin-6 (IL-6) level, IL-6–174G>C gene polymorphism, and insulin resistance affect the response to antiviral treatment in HCV-infected patients.

Patients and methods: Fifty-five chronic hepatitis C patients and 13 healthy individuals as controls were included in this study. Liver function tests, HCV RNA titer, ultrasonography, and histopathological examination of liver tissues were performed for all patients. Pretreatment plasma IL-6 levels and homeostasis model assessment-insulin resistance were estimated. The IL-6–174G>C polymorphism was detected by the PCR/RFLP method. After 12 weeks of combined pegylated interferon-α and ribavirin therapy, patients were classified into responders or nonresponders according to whether they achieved an early virological response.

Results: The responders had significantly high IL-6 levels (P=0.01), low mean stage of fibrosis (P=0.03), and low viral load (P=0.04) compared with nonresponders. Although not significant, patients with the IL-6–174 CC genotype reported a higher response rate (81%) compared with those with the CG genotype (50%) and GG genotype (62%). IL-6 level at a cutoff point of 2.15 pg/ml had 81.1% sensitivity and 72.7% specificity and showed significant relation with early virological response (P=0.04).

Conclusion: Estimation of basal IL-6 level could be used as a predictor of response to pegylated interferon-α and ribavirin therapy in CHC patients.

sted, utgiver, år, opplag, sider
Heidelberg, Germany: Wolters Kluwer, 2013. Vol. 3, nr 2, s. 21-27
Emneord [en]
chronic hepatitis C; insulin resistance; interleukin-6; response to pegylated interferon-α and ribavirin
HSV kategori
Identifikatorer
URN: urn:nbn:se:liu:diva-184598Scopus ID: 2-s2.0-84879368645OAI: oai:DiVA.org:liu-184598DiVA, id: diva2:1654193
Tilgjengelig fra: 2022-04-26 Laget: 2022-04-26 Sist oppdatert: 2022-05-04bibliografisk kontrollert

Open Access i DiVA

Fulltekst mangler i DiVA

Andre lenker

ScopusLink to publication

Person

El Serafi, Ibrahim TaherEl Serafi, Ahmed Taher

Søk i DiVA

Av forfatter/redaktør
El Serafi, Ibrahim TaherEl Serafi, Ahmed Taher

Søk utenfor DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric

urn-nbn
Totalt: 36 treff
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf